PortfoliosLab logo
BX vs. VRTX
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between BX and VRTX is 0.28, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.0
Correlation: 0.3

Maximize Your Portfolio’s Potential

Does your portfolio have the optimal asset allocation aligned with your goals? Find it out with our portfolio optimizer

Try portfolio optimization now

Performance

BX vs. VRTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in The Blackstone Group Inc. (BX) and Vertex Pharmaceuticals Incorporated (VRTX). The values are adjusted to include any dividend payments, if applicable.

-20.00%-10.00%0.00%10.00%20.00%30.00%NovemberDecember2025FebruaryMarchApril
-16.56%
4.24%
BX
VRTX

Key characteristics

Sharpe Ratio

BX:

0.04

VRTX:

0.63

Sortino Ratio

BX:

0.28

VRTX:

0.95

Omega Ratio

BX:

1.04

VRTX:

1.14

Calmar Ratio

BX:

0.04

VRTX:

0.69

Martin Ratio

BX:

0.12

VRTX:

1.90

Ulcer Index

BX:

11.45%

VRTX:

8.47%

Daily Std Dev

BX:

33.33%

VRTX:

25.58%

Max Drawdown

BX:

-87.64%

VRTX:

-91.77%

Current Drawdown

BX:

-36.65%

VRTX:

-8.15%

Fundamentals

Market Cap

BX:

$152.38B

VRTX:

$122.02B

EPS

BX:

$3.63

VRTX:

-$2.09

PEG Ratio

BX:

1.56

VRTX:

1.30

Total Revenue (TTM)

BX:

$9.13B

VRTX:

$8.32B

Gross Profit (TTM)

BX:

$9.13B

VRTX:

$7.13B

EBITDA (TTM)

BX:

$4.43B

VRTX:

-$856.70M

Returns By Period

In the year-to-date period, BX achieves a -26.86% return, which is significantly lower than VRTX's 17.86% return. Over the past 10 years, BX has outperformed VRTX with an annualized return of 18.37%, while VRTX has yielded a comparatively lower 14.73% annualized return.


BX

YTD

-26.86%

1M

-17.76%

6M

-16.56%

1Y

1.86%

5Y*

29.04%

10Y*

18.37%

VRTX

YTD

17.86%

1M

-3.46%

6M

4.24%

1Y

17.48%

5Y*

14.81%

10Y*

14.73%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


The Blackstone Group Inc.

Risk-Adjusted Performance

BX vs. VRTX — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BX
The Risk-Adjusted Performance Rank of BX is 5353
Overall Rank
The Sharpe Ratio Rank of BX is 5656
Sharpe Ratio Rank
The Sortino Ratio Rank of BX is 4848
Sortino Ratio Rank
The Omega Ratio Rank of BX is 4848
Omega Ratio Rank
The Calmar Ratio Rank of BX is 5656
Calmar Ratio Rank
The Martin Ratio Rank of BX is 5656
Martin Ratio Rank

VRTX
The Risk-Adjusted Performance Rank of VRTX is 7373
Overall Rank
The Sharpe Ratio Rank of VRTX is 7777
Sharpe Ratio Rank
The Sortino Ratio Rank of VRTX is 6767
Sortino Ratio Rank
The Omega Ratio Rank of VRTX is 6868
Omega Ratio Rank
The Calmar Ratio Rank of VRTX is 8080
Calmar Ratio Rank
The Martin Ratio Rank of VRTX is 7474
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BX vs. VRTX - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for The Blackstone Group Inc. (BX) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for BX, currently valued at 0.04, compared to the broader market-2.00-1.000.001.002.00
BX: 0.04
VRTX: 0.63
The chart of Sortino ratio for BX, currently valued at 0.28, compared to the broader market-6.00-4.00-2.000.002.004.00
BX: 0.28
VRTX: 0.95
The chart of Omega ratio for BX, currently valued at 1.04, compared to the broader market0.501.001.502.00
BX: 1.04
VRTX: 1.14
The chart of Calmar ratio for BX, currently valued at 0.04, compared to the broader market0.001.002.003.004.00
BX: 0.04
VRTX: 0.69
The chart of Martin ratio for BX, currently valued at 0.12, compared to the broader market-10.000.0010.0020.00
BX: 0.12
VRTX: 1.90

The current BX Sharpe Ratio is 0.04, which is lower than the VRTX Sharpe Ratio of 0.63. The chart below compares the historical Sharpe Ratios of BX and VRTX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.00NovemberDecember2025FebruaryMarchApril
0.04
0.63
BX
VRTX

Dividends

BX vs. VRTX - Dividend Comparison

BX's dividend yield for the trailing twelve months is around 3.16%, while VRTX has not paid dividends to shareholders.


TTM20242023202220212020201920182017201620152014
BX
The Blackstone Group Inc.
3.16%2.00%2.54%6.66%2.76%2.95%3.43%8.12%7.25%8.44%9.81%5.63%
VRTX
Vertex Pharmaceuticals Incorporated
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

BX vs. VRTX - Drawdown Comparison

The maximum BX drawdown since its inception was -87.64%, roughly equal to the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for BX and VRTX. For additional features, visit the drawdowns tool.


-40.00%-30.00%-20.00%-10.00%0.00%NovemberDecember2025FebruaryMarchApril
-36.65%
-8.15%
BX
VRTX

Volatility

BX vs. VRTX - Volatility Comparison

The Blackstone Group Inc. (BX) has a higher volatility of 16.54% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 6.30%. This indicates that BX's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


6.00%8.00%10.00%12.00%14.00%16.00%NovemberDecember2025FebruaryMarchApril
16.54%
6.30%
BX
VRTX

Financials

BX vs. VRTX - Financials Comparison

This section allows you to compare key financial metrics between The Blackstone Group Inc. and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


-2.00B-1.00B0.001.00B2.00B3.00B4.00BAprilJulyOctober2021AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober
2.81B
2.91B
(BX) Total Revenue
(VRTX) Total Revenue
Values in USD except per share items

User Portfolios with BX or VRTX


TFM
0%
YTD
CVX
SU.PA
SRG.MI
TRN.MI
AENA.MC
BX
CSX
DG.PA
COL.MC
FPI
WELL
PLD
BG
VRLA.PA
FNV.TO
AAL.L
CNQ
FCX
CLNX.MC
PRY.MI
NEX.PA
IBE.MC
PNR
VIE.PA
WM
GOOGL
AMZN
AEE
AEP
AFG
ADI
META
FR
FI
GILD
INTU
JPM
ORLY
ORCL
PAYX
PM
PG
PGR
AAPL
AMAT
ADP
AZO
BAC
BKNG
BAH
AVGO
CBOE
CI
KO
CL
CMCSA
CMPGY
DLB
EA
EXPGY
XOM
ADRNY
LHX
LDOS
LLY
LMT
LULU
MTB
MSCI
MMC
MA
MCK
MRK
MSFT
NTAP
NYT
NICE
GEN
NVDA
PSA
RGA
RELX
SHEL
SPGI
CRM
NOW
SHW
STN
TSM
TMO
UNH
VZ
VRTX
V
WMT
YUM
DOX
ETN
EG
G
MDT
QQQ
ABBV
ADBE
ACM
BIL
GLD
GBTC
1 / 47

Recent discussions